1. Home
  2. BCTXL vs NEWTP Comparison

BCTXL vs NEWTP Comparison

Compare BCTXL & NEWTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BriaCell Therapeutics Corp. Warrant expiring 2031

BCTXL

BriaCell Therapeutics Corp. Warrant expiring 2031

N/A

Current Price

$0.88

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo NewtekOne Inc. Depositary Shares Non-Cumulative Perpetual Preferred Stock Series B

NEWTP

NewtekOne Inc. Depositary Shares Non-Cumulative Perpetual Preferred Stock Series B

N/A

Current Price

$24.35

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BCTXL
NEWTP
Founded
N/A
N/A
Country
Canada
United States
Employees
4
572
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCTXL
NEWTP
Price
$0.88
$24.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.3K
5.0K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$22.51
52 Week High
$1.40
$24.69

Technical Indicators

Market Signals
Indicator
BCTXL
NEWTP
Relative Strength Index (RSI) 47.17 60.04
Support Level $0.92 $23.69
Resistance Level $1.21 N/A
Average True Range (ATR) 0.09 0.20
MACD -0.00 -0.00
Stochastic Oscillator 49.19 87.59

Price Performance

Historical Comparison
BCTXL
NEWTP

About BCTXL BriaCell Therapeutics Corp. Warrant expiring 2031

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About NEWTP NewtekOne Inc. Depositary Shares Non-Cumulative Perpetual Preferred Stock Series B

NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.

Share on Social Networks: